1. Topics and Faculty
Introduction and Program Overview
Janice Dunsavage, RPh, MAS, Chair, ISMP
Board of Trustees and Director of Pharmacy,
PinnacleHealth, Harrisburg, PA
Primer on Medication Administration
Systems and Medications Used in
Radiology
Lior Molvin, (MBA) (RT) (R) (CT), CT Protocol
Technologist, CT Protocol Development and
Education Team, Stanford University Medical
Center and Stanford Medicine, Imaging
Center, Palo Alto, CA
Medication Safety Issues and
Recommended Strategies
Matthew P. Fricker, Jr, MS, RPh, FASHP,
Program Director, ISMP
Centers for Medicare & Medicaid
Services (CMS) and The Joint
Commission Requirements
Darryl S. Rich, PharmD, MBA, FASHP,
Medication Safety Specialist, ISMP
Question and Answer Session
Janice Dunsavage, RPh, MAS, Chair, ISMP
Board of Trustees and Director of Pharmacy,
PinnacleHealth, Harrisburg, PA
This CE activity is funded
through an educational grant
from Bracco Diagnostics.
Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797 www.ismp.org
For registration questions, contact ProCE at 1-800-748-7795.
Activity Description
Radiology departments often use medications in ways that are different from other clinical
areas of the hospital, and staff may not be aware of the significant safety issues that can arise.
This webinar will explore current medication safety issues in the radiology setting, such as
the safe use of contrast, appropriate labeling of containers, beyond-use dating, and patient
identification. Nationally known experts will discuss actual cases in which errors have occurred,
and will describe risk-reduction strategies, including use of technology and best practices.
Faculty will also discuss an Imaging Bulk Package for contrast recently approved by the US
Food and Drug Administration, as well as regulatory and Joint Commission accreditation
requirements for use of contrast and other medications in radiology.
Learning Objectives
The target audience for this activity includes pharmacists and radiologic technologists.
At the completion of this activity, the participant should be able to:
• Describe how medications and contrast agents are ordered, stored, prepared, and utilized
in the radiology setting.
• Explain the difference between the new FDA classification of an imaging bulk package vs.
a pharmacy bulk package of contrast, and why FDA developed this new product type.
• Identify system-based causes of medication errors associated with the use of medications
and contrast agents in radiology.
• Prioritize selected strategies to prevent harm and improve medication safety in radiology.
• Describe current regulatory and accreditation requirements related to the use of medications
and contrast agents in radiology, and the role of the pharmacy in assuring compliance with
the standards.
Accreditation
Pharmacists: This CE activity is jointly provided by ProCE, Inc. and the Institute
for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE Universal Activity Number 0221-9999-15-089-H05-P has been assigned to
this knowledge-based, home-study activity.
This CE activity is approved for 2.0 contact hours (0.20 CEU) in states that
recognize ACPE providers, and is provided at no cost to participants. Completion
of an evaluation and post-test with a score of 70% or higher is required to receive
CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will
be given.
Radiologic Technologists: Approved by the ASRT for Category A continuing
education credit.
Improving Medication Safety in
the Radiology Setting
This CE activity is available as an On-Demand Webinar at www.ProCE.com/Radiology
CE CREDIT
OPPORTUNITY:
ON-DEMAND WEBINAR
Release Date:
June 15, 2015
Expiration Date:
June 15, 2018